Skip to content Skip to footer

GBM AGILE

GBM – One of the Most Deadly Cancers GBM continues to face limited treatment options and devastating survival rates. AFCR is committed to accelerating breakthrough solutions. The Urgent Need for Innovation 95%​ GBM kills 95% of patients within five years of diagnosis​ 240,000​ Each Year,…

Read More

AFCR Symposium at BIOHK

Collaborating for Global Cancer Innovation BIOHK is an international biotechnology convention that brings together researchers, clinicians, entrepreneurs, industry leaders and investors to exchange knowledge, build partnerships and advance biomedical innovation. The Asian Fund for Cancer Research Limited (AFCR), through its partnerships with…

Read More